Terms: = Germ cell tumor AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1
322 results:
1. Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics.
Dhamdhere MR; Spiegelman VS
Front Immunol; 2024; 15():1385875. PubMed ID: 38660306
[TBL] [Abstract] [Full Text] [Related]
2. Primary Hepatic Neuroblastoma in a 5.5-Month-Old Boy: A Case Report.
Kompani F; Safari Sharari A; Haji Esmaeil Memar E; Ghahremanloo M
Arch Iran Med; 2024 Jan; 27(1):44-47. PubMed ID: 38431960
[TBL] [Abstract] [Full Text] [Related]
3. DNA damage remodels the MITF interactome to increase melanoma genomic instability.
Binet R; Lambert JP; Tomkova M; Tischfield S; Baggiolini A; Picaud S; Sarkar S; Louphrasitthiphol P; Dias D; Carreira S; Humphrey TC; Fillipakopoulos P; White R; Goding CR
Genes Dev; 2024 Feb; 38(1-2):70-94. PubMed ID: 38316520
[TBL] [Abstract] [Full Text] [Related]
4. Contribution of plasma MicroRNA-21, MicroRNA-155 and circulating monocytes plasticity to childhood neuroblastoma development and induction treatment outcome.
Hammad R; Selim M; Eldosoky MA; Elmadbouly AA; Abd El Hakam FE; Elshafei A; Fawzy M; Hammad M
Pathol Res Pract; 2024 Feb; 254():155060. PubMed ID: 38194805
[TBL] [Abstract] [Full Text] [Related]
5. PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma.
Song M; Huang Y; Hong Y; Liu J; Zhu J; Lu S; Wang J; Sun F; Huang J; Xu J; Tang Y; Xia JC; Zhang Y
Oncoimmunology; 2024; 13(1):2289738. PubMed ID: 38125723
[TBL] [Abstract] [Full Text] [Related]
6. Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With Cancer With Different Oral Toxicity Profiles.
Xu Y; Wen N; Haddad RI; Sonis ST; Villa A
Oncologist; 2024 Mar; 29(3):e382-e391. PubMed ID: 37874927
[TBL] [Abstract] [Full Text] [Related]
7. Analysing the causal relationship between potentially protective and risk factors and cutaneous melanoma: A Mendelian randomization study.
Liu M; Lan Y; Zhang H; Wu M; Zhang X; Leng L; Zheng H; Li J
J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):102-111. PubMed ID: 37712456
[TBL] [Abstract] [Full Text] [Related]
8. Asymmetric Adrenals: Sexual Dimorphism of Adrenal tumors.
Bechmann N; Moskopp ML; Constantinescu G; Stell A; Ernst A; Berthold F; Westermann F; Jiang J; Lui L; Nowak E; Zopp S; Pacak K; Peitzsch M; Schedl A; Reincke M; Beuschlein F; Bornstein SR; Fassnacht M; Eisenhofer G
J Clin Endocrinol Metab; 2024 Jan; 109(2):471-482. PubMed ID: 37647861
[TBL] [Abstract] [Full Text] [Related]
9. Neural crest-related NXPH1/α-NRXN signaling opposes neuroblastoma malignancy by inhibiting organotropic metastasis.
Fanlo L; Gómez-González S; Rozalén C; Pérez-Núñez I; Sangrador I; Tomás-Daza L; Gautier EL; Usieto S; Rebollo E; Vila-Ubach M; Carcaboso AM; Javierre BM; Celià-Terrassa T; Lavarino C; Martí E; Le Dréau G
Oncogene; 2023 Jul; 42(28):2218-2233. PubMed ID: 37301928
[TBL] [Abstract] [Full Text] [Related]
10. Simultaneous nbs1 and p53 inactivation in neural progenitors triggers high-grade gliomas.
Reuss DE; Downing SM; Camacho CV; Wang YD; Piro RM; Herold-Mende C; Wang ZQ; Hofmann TG; Sahm F; von Deimling A; McKinnon PJ; Frappart PO
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12915. PubMed ID: 37296499
[TBL] [Abstract] [Full Text] [Related]
11. Hydrogen nanobubbles: A novel approach toward radio-sensitization agents.
Hashemi S; Aghamiri SM; Siavashpour Z; Kahani M; Zaidi H; Jaberi R
Med Phys; 2023 Oct; 50(10):6589-6599. PubMed ID: 37278345
[TBL] [Abstract] [Full Text] [Related]
12. Retroperitoneal localized neuroblastoma in children: a comparison of enhanced recovery after surgery versus traditional care.
Zhu K; He J; Chen T; Yu X; He X; Su Y
Pediatr Surg Int; 2023 Jun; 39(1):208. PubMed ID: 37261573
[TBL] [Abstract] [Full Text] [Related]
13.
De Rosa P; Severi F; Zadran SK; Russo M; Aloisi S; Rigamonti A; Capranico G; Milazzo G; Perini G
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982482
[TBL] [Abstract] [Full Text] [Related]
14. New pathogenic germline variants identified in mesothelioma.
Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
[TBL] [Abstract] [Full Text] [Related]
15. Drug repurposing of propafenone to discover novel anti-tumor agents by impairing homologous recombination to delay DNA damage recovery of rare disease conjunctival melanoma.
Wei J; Li Y; Li R; Chen X; Yang T; Liao L; Xie Y; Zhu J; Mao F; Jia R; Xu X; Li J
Eur J Med Chem; 2023 Mar; 250():115238. PubMed ID: 36868105
[TBL] [Abstract] [Full Text] [Related]
16. RBBP4 regulates the expression of the Mre11-Rad50-nbs1 (MRN) complex and promotes DNA double-strand break repair to mediate glioblastoma chemoradiotherapy resistance.
Li J; Song C; Gu J; Li C; Zang W; Shi L; Chen L; Zhu L; Zhou M; Wang T; Li H; Qi S; Lu Y
Cancer Lett; 2023 Mar; 557():216078. PubMed ID: 36736531
[TBL] [Abstract] [Full Text] [Related]
17. Comparative epigenomics by machine learning approach for neuroblastoma.
Sugino RP; Ohira M; Mansai SP; Kamijo T
BMC Genomics; 2022 Dec; 23(1):852. PubMed ID: 36572864
[TBL] [Abstract] [Full Text] [Related]
18. nbn Pathogenic germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.
Belhadj S; Khurram A; Bandlamudi C; Palou-Márquez G; Ravichandran V; Steinsnyder Z; Wildman T; Catchings A; Kemel Y; Mukherjee S; Fesko B; Arora K; Mehine M; Dandiker S; Izhar A; Petrini J; Domchek S; Nathanson KL; Brower J; Couch F; Stadler Z; Robson M; Walsh M; Vijai J; Berger M; Supek F; Karam R; Topka S; Offit K
Clin Cancer Res; 2023 Jan; 29(2):422-431. PubMed ID: 36346689
[TBL] [Abstract] [Full Text] [Related]
19. Stage M Infantile Neuroblastoma With Involvement of Falx Cerebri: Case Report and Literature Review.
Sai M; Moriya K; Kaino A; Suzuki T; Katayama S; Aoki H; Sasahara Y
J Pediatr Hematol Oncol; 2023 May; 45(4):220-222. PubMed ID: 36161989
[TBL] [Abstract] [Full Text] [Related]
20. Doxorubicin-Induced TrkAIII Activation: A Selection Mechanism for Resistant Dormant Neuroblastoma cells.
Cappabianca L; Sebastiano M; Ruggieri M; Sbaffone M; Zelli V; Farina AR; Mackay AR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142807
[TBL] [Abstract] [Full Text] [Related]
[Next]
